Mental Health

Bipolar Disorder and Schizophrenia Spectrum Disorders impact not only the person who has the illness but also the lives of family members and friends who help support them.

By completing an online survey, you will be contributing to a better understanding of caregiver experiences. This information will be particularly helpful for working out ways to better support caregivers. The questions will ask you to reflect on your experience and thoughts about caregiving and how you have been going in different areas of your life with regard to your health, work, relationships, beliefs, and wellbeing.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Hidradenitis suppurativa (HS) is a chronic inflammatory debilitating skin condition characterised by painful, deep skin lesions commonly under the arms or in the groin area. It can be treated with topical treatments on the skin, tablets, injections or infusions.

The investigational drug for this study is called bimkizumab and is given as an injection into the skin.

The purpose of this research project is to measure how safe and effective this medication is in treating participants with HS. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of HS and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Pemphigus is a rare, autoimmune skin condition characterised by blistering and itchiness. Many patients who have pemphigus require treatment with topical steroids, tablets, injections or infusions.

The purpose of this research project is to measure how safe and effective efgartigimod is in treating participants with pemphigus also receiving oral corticosteroids. Efgartigimod is injected into the skin.

Prior research studies in humans have shown that efgartigimod may help control the immune system that is responsible for the signs and symptoms of pemphigus and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Generalised pustular psoriasis is a rare skin disorder that presents with flares of widespread pustules on a background of red and tender skin. It can be treated with special creams for the skin, tablets or injections.

The investigational drug for this study is called spesolimab and is given as an injection into the skin.

The purpose of this research project is to measure how safe and effective this medication is in treating participants with generalised pustular psoriasis. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of generalised pustular psoriasis and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Hidradeninitis Suppurativa (HS) is a chronic inflammatory debilitating skin condition characterised by painful, deep skin lesions commonly under the arms or in the groin area. It can be treated with topical treatments on the skin, tablets, injections or infusions.

The investigational drug for this study is called spesolimab and given as an injection into the skin.

The purpose of this research project is to measure how safe and effective this medication is in treating participants with HS. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of HS and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Hidradeninitis Suppurativa is a chronic inflammatory debilitating skin condition characterised by painful, deep skin lesions commonly under the arms or in the groin area. It can be treated with topical treatments on the skin, tablets, injections or infusions.

The investigational drug is given as an injection into the skin and targets one part of the pathway involved in HS.

The purpose of this research project is to measure how safe and effective this medication is in treating participants with hidradenitis suppurativa. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of hidradenitis suppurativa and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Atopic dermatitis is a condition that makes your skin red, itchy and prone to infections. It can be treated with special creams for the skin, tablets or injections.

The investigational drug for this study is called benralizumab and given as an injection into the skin.

The purpose of this research project is to measure how safe and effective this medication is in treating participants with atopic dermatitis. Prior research studies in humans have shown that this medication may help control the immune system that is responsible for the signs and symptoms of atopic dermatitis and help achieve disease improvement.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dementia

The main purpose of this research project is to look at whether the trial drug, sodium selenate decreases the rate of brain shrinkage in patients with fronto-temporal dementia. The research project will also look into the effect of sodium selenate on brain function and markers of disease measured on brain scans, in blood, and in the fluid around the brain and spine to see if participants are responding to the treatment.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4